Mycobacterium tuberculosis infection: A rare late complication after cord blood hematopoietic SCT

Bone Marrow Transplantation

Volumn 43, Issue 8, 2009, Pages 667-668

  De Assis, R A ^a   Kerbauy, F R ^a   Rodrigues, M ^a   Seguro, F S ^a   Aranha, L F C ^a   Fayad, L ^b   Shpall, E J ^b   de Lima, M ^b   Hamerschlak, N ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETHAMBUTOL; ETOPOSIDE; FLUDARABINE; FLUORODEOXYGLUCOSE; GEMCITABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; ISONIAZID; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; RITUXIMAB; STEROID; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACKACHE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CONTRAST ENHANCEMENT; CORD BLOOD STEM CELL TRANSPLANTATION; FEVER; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER METASTASIS; LUNG ABSCESS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYCOBACTERIUM TUBERCULOSIS; MYELOABLATIVE CONDITIONING; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALVAGE THERAPY; THORAX PAIN; TREATMENT RESPONSE; TUBERCULOSIS; WHOLE BODY RADIATION;

ADULT; DISEASE PROGRESSION; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; POSITRON-EMISSION TOMOGRAPHY; REMISSION INDUCTION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 67349086087     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.379     Document Type: Article

References (11)

1. Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D et al. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: Focus on the use of cord blood products. Bone Marrow Transplant 2008; 41: 687-705.
2. Rocha V, Garnier F, Ionescu I, Gluckman E, Eurocord and European Blood and Marrow Transplant Group. Hematopoietic stem-cell transplantation using umbilical-cord blood cells. Rev Invest Clin 2005; 57: 314-323.
3. George B, Mathews V, Srivastava A, Chandy M. Infections among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2004; 33: 311-315.
4. Aljurf M, Gyger M, Alrajhi A, Sahovic E, Chaudhri N, Musa M et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551-554.
5. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: A 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467-470.
6. Yuen KY, Woo PC. Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002; 20: 51-62.
7. Navari RM, Sullivan KM, Springmeyer SC, Siegel MS, Meyers JD, Buckner CD et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36: 509-513.
8. de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS et al. Transplantation of ex vivo expanded cord blood cells using the copper chelatortetr aethylenepentamine: A phase I/II clinical trial. Bone Marrow Transplant 2008; 41: 771-778.
9. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica. Ministério da Saúde: Brasília, 2005. Available at http://bvsms.saude.gov.br/ bvs/publicacoes/Guia_Vig_Epid_novo2.pdf. Accessed in 2008 (September15).
10. Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS et al Mycobacterial infection: A difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis 2004; 38: 1229-1236.
11. Maeda T, Kusumi E, Kami M, Kawabata M, Le Pavoux A, Hara S et al. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases. Bone Marrow Transplant 2005; 35: 91-97.